16 Patents
- US125901332026IL-13/IL-4 Superkines: Immune Cell Targeting Constructs and Methods of Use Thereof
Medicenna Therapeutics Inc.
0 cites - US124668682025Engineered Proteins to Enhance Sensitivity of a Cell to IL-2
Park Institute For Cancer Immunotherapy
0 cites - US124102262025Interferon-gamma Biased Agonists
The Board Of Trustees Of The Leland Stanford Junior University
0 cites - US122408802025De Novo Design of Potent and Selective Interleukin Mimetics
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
0 cites - US122275532025De Novo Design of Potent and Selective Interleukin Mimetics
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
0 cites - US122214692025Switch Receptors Using IL-9 Signaling Domains
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
0 cites - US121955322025High Affinity Sirp-alpha Reagents and Methods of Using
The Board Of Trustees Of The Leland Stanford Junior University
0 cites - US120914412024Partial Agonists of Interleukin-2
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
0 cites - 0 cites
- 0 cites
- US120063472024Superagonists and Antagonists of Interleukin-2
The Board Of Trustees Of The Leland Stanford Junior University
0 cites - US119936392024Therapeutic IL-13 Polypeptides
The Board Of Trustees Of The Leland Stanford Junior University
0 cites - US119936452024Compositions Comprising R-spondin (RSPO) Surrogate Molecules
The Board Of Trustees Of The Leland Stanford Junior University
0 cites - 0 cites
- US117808992023Engineered Proteins to Enhance Sensitivity of a Cell to IL-2
Parker Institute For Cancer Immunotherapy
0 cites - US116552782023De Novo Design of Potent and Selective Interleukin Mimetics
THE LELAND STANFORD JUNIOR UNIVERSITY
0 cites